• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in this journal  Topic Collections  • Psychiatry  • Psychiatry, Other  • Quality of Care  • Evidence-Based Medicine  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I am writing on behalf of the National Mental Health Association (NMHA) in response to the article titled "Off-label Prescribing Among Office-Based Physicians" by Radley et al.¹

As an organization, NMHA is concerned with the inappropriate prescribing of medications; however, we are also concerned about the potential to conclude from the study by Radley et al,¹ that all off-label prescribing is inappropriate. The study's conclusion that off-label use of medications lacks rigorous scientific scrutiny has strong implications and could lead to a false assumption about the usefulness of off-label prescribing.

While there is a dearth of scientific research on off-label prescribing, off-label treatments can be grounded in top-notch research and have proved to be beneficial for many individuals. At NMHA, we believe that this study does not highlight the positive outcomes that can result from off-label prescribing practices. Through the appropriate use of off-label prescriptions, physicians can successfully determine the . . . [Full Text of this Article]

AUTHOR INFORMATION
Jennifer L. Bright, MPA

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Positive Outcomes Through the Appropriate Use of Off-Label Prescribing—Reply
Randall S. Stafford, David C. Radley, and Stan N. Finkelstein
Arch Intern Med. 2006;166(22):2555.
EXTRACT | FULL TEXT